MOHAMMAD A SARRAF

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease SOUTH PLAINFIELD, NJ NPI 1689648735

General Payments — all program years on this page

$1,328.39

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 87
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $233.83 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $233.8315

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $237.1717
2019 $500.7536
2020 $136.129
2021 $13.621
2022 $28.592
2023 $178.317
2024 $233.8315

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078901423 Actelion Pharmaceuticals US, Inc. $17.00 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901425 Actelion Pharmaceuticals US, Inc. $1.83 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901427 Actelion Pharmaceuticals US, Inc. $16.86 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901429 Actelion Pharmaceuticals US, Inc. $16.90 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901431 Actelion Pharmaceuticals US, Inc. $16.98 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901433 Actelion Pharmaceuticals US, Inc. $15.14 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901435 Actelion Pharmaceuticals US, Inc. $16.99 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901437 Actelion Pharmaceuticals US, Inc. $16.97 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078901439 Actelion Pharmaceuticals US, Inc. $16.65 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087340211 Novartis Pharmaceuticals Corporation $14.54 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116594260 GlaxoSmithKline, LLC. $16.38 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131065323 PFIZER INC. $15.00 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131231617 PFIZER INC. $19.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146857557 Philips North America LLC $16.45 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146857559 Philips North America LLC $17.14 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.